Essex Bio-Technology (1061.HK) Earnings Analysis
Essex Bio-Technology (1061.HK) next reports earnings on 2026-09-01. Trailing P/E 4.48.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1061.HK next report earnings?
| Next earnings date | 2026-09-01 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
1061.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-26 | 0.2882 HKD | n/a | n/a | n/a |
| 2024-08-26 | 0.2655 HKD | n/a | n/a | n/a |
1061.HK valuation and analyst view
| Trailing P/E | 4.48 |
|---|---|
| Trailing EPS | 0.56096 HKD |
| Price / book | 0.59 |
| Dividend yield | 5.58% |
| Market cap | 1.43B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Essex Bio-Technology (1061.HK)'s next earnings date?
Essex Bio-Technology is next scheduled to report on 2026-09-01.
Did 1061.HK beat earnings last quarter?
Consensus estimate data was not available for 1061.HK's 2025-08-26 report.
What is 1061.HK's current P/E ratio and EPS?
1061.HK trades at a trailing P/E of 4.48 on trailing EPS of 0.5609597248826127 HKD.
What do analysts rate 1061.HK?
1061.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.